Skip to main content

What the FDA labels say about taking them together

Eplerenone and erythromycin

Eplerenone's FDA label of June 23, 2025 names erythromycin in its drug interactions section; the erythromycin labels PlainMeds reads (4) do not name eplerenone. The eplerenone label: “CYP3A Inhibitors: In post-MI HFrEF patients, do not exceed 25 mg once daily when used with moderate CYP3A inhibitors.”

Check it at the source: the eplerenone FDA label on DailyMed (effective June 23, 2025, Viatris Specialty LLC); the erythromycin FDA label on DailyMed (effective August 1, 2024, Teva Pharmaceuticals USA, Inc.).

What does the eplerenone label say about erythromycin?

Eplerenone label, drug interactions

CYP3A Inhibitors: In post-MI HFrEF patients, do not exceed 25 mg once daily when used with moderate CYP3A inhibitors (e.g., verapamil, erythromycin, saquinavir, fluconazole).

Source: FDA drug label (Inspra), NDA021437 (Upjohn), as published by Viatris Specialty LLC, effective June 23, 2025 (SPL set 1a52bedc-8e2c-4116-a296-a87770676b4a), via openFDA; the full label on DailyMed

What does the erythromycin label say about eplerenone?

Erythromycin's label (effective August 1, 2024) and its 3 other brand-application labels do not name eplerenone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Erythromycin), Teva Pharmaceuticals USA, Inc., effective August 1, 2024 (SPL set 75a0bd5a-d09f-483b-bfd8-f8343b149eb2), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

9Eplerenone generic labelers
38Erythromycin generic labelers
EplerenoneErythromycin
Labeled forHeart failure, High blood pressureBacterial infections, Acne
Boxed warningNoNo
Pharmacy cost (NADAC)$0.308 per tablet 25 mg tablet$1.96 per tablet 250 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?